NCT02528760已完成不适用
To Determine the Role of Prokinetics in Feed Intolerance in Critically Ill Cirrhosis- A Randomized Placebo Controlled Study
适应症
干预措施
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 83
- 试验地点
- 1
- 主要终点
- Resolution of feed intolerance at 24 hours with improvement in 3 or more points and initiation of entral feeding.
研究概览
简要总结
- All patients with chronic liver disease admitted in ICU (Intensive Care Unit) to be screened.
- Patients fulfilling criteria for feed intolerance to be included in the study.
- Patients to undergo routine biochemical and hematological testing including CBC, KFT, LFT, PT/INR, electrolytes baseline and daily along with ABG (Arterial Blood gas) analysis.
- Patients with ascites to be tested for presence or absence of SBP (Spontaneous Bacterial Peritonitis).
- Cultures to be sent as based on clinical parameter of the patient.
- All correctable causes for intra abdominal hypertension to be corrected including electrolyte imbalance, grade III ascites, intra abdominal infection.
- Symptoms- Absent bowel sounds (BS)= no BS detected by auscultation. Vomiting/regurgitation= any visible regurgitation of gastric contents; Diarrhoea= liquid stool > or =3 times/day; Bowel distension= suspected clinically and radiologically confirmed; Large gastric residual volume (GRV) of >or =500 ml/24 h on a single day or > 200ml at any time of the day.
- Per abdomen findings to be checked daily including presence of bowel sounds, tenderness, development of abdominal distension, abdominal girth monitoring and abdominal pressure monitoring.
- Patients who develop feed intolerance will be included.
- Feed intolerance to be defined as per study definition (3 out of 5 symptoms).
- Measurement of GRV (Gastric residual volume) to be done at 4 hourly interval.
- Methods for measuring GRV by either gravity drainage by connecting a gastric tube to a drainage bag for 10min or by manual aspiration of content using a 50ml syringe.
- Once feed intolerance develop than every 6 hourly intra abdominal pressure monitoring and abdominal girth monitoring to be done (24)
- Intra bladder pressure to be measured using Foleys manometer technique (25).
- Pressure measured in cm of water to be converted into mm of Hg.
- X ray abdomen supine to look for bowel distension, defined as more than 3 cm for small bowel and more than 5 cm in large bowel.
- Development of intra abdominal hypertension based on intra abdominal pressure.
- Patient to be stratified according to the grade of intra-abdominal hypertension.
- After correction of all correctable causes, if feed intolerance persists, then patient to be randomized by block randomization method into 3 arms, metaclopromide group, erythromycin group or placebo group.
- Daily assessment of bowel sounds, abdominal pressure, abdominal girth every 6 hourly and gastric residual volume to be noted every 4 hourly.
- Response of therapy to be assessed at 24 hours in each arm.
- Response to be assessed by resolution of feed intolerance or initiation of entral nutrition.
- Metoclopromide to be given 10mg iv 8 hourly.
- Erythromycin to be given 70mg iv 12 hourly (26).
- Placebo arm to receive normal saline in 10ml syring twice daily.
- After 24 hours of treatment if symptoms do not resolve than rescue treatment will be given to each arm which may include continuation of prokinetics, add on prokinetic, flatus tube insertion for bowel decompression, upgradation of antibiotics or search for any other cause, as per the patient response.
- Therapy to continue for a total duration of 72 hours.
- If there is no response at 72 hours, than study stops.
- If patient responds to given treatment, study to continue for a total duration of 7 days.
- Assessment to continue in each arm for a maximum period of 7 days.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 70 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients who develop new onset feed intolerance to enteral nutrition
排除标准
- •Any patient with current or past surgical abdomen including mechanical obstruction, mesenteric ischemia, perforation or requiring abdominal surgery.
- •Patients receiving enteral nutrition through gastrostomy or jejunostomy.
- •Patients in whom, prokinetics are contraindicated or are allergic to the same.
- •Patients who received prokinetic more than one day prior to the start of enteral feeding.
- •Patients with uncontrolled sepsis with DIC.
- •Requirement of two or more vasopressors.
- •Organ failure requiring high inotropic support.
- •Advanced cardiopulmonary disease, with prior history of arrhythmias, structural heart disease.
- •History of traumatic brain injury, raised intracranial pressure, history of myasthenia gravis.
- •Endocronolgic illnesses: Hypothyroidism, hypoparathyroidism
- •Connective tissue diseases (systemic sclerosis, dermatomyositis or polymyositis, systemic lupus erythematosis, amyloidosis).
- •Known case of diabetes with diabetic gastroparesis
- •Patients or concerned family member who fail to give consent for study enrollment
- •Age less than 18 years and more than 70 years.
研究组 & 干预措施
Metaclopromide group
Experimental
干预措施: Metaclopramide (Drug)
Erythromycin group
Experimental
干预措施: Erythromycin (Drug)
Placebo group
Placebo Comparator
干预措施: Placebo (Other)
结局指标
主要结局
Resolution of feed intolerance at 24 hours with improvement in 3 or more points and initiation of entral feeding.
时间窗: 24 hours
Feed intolerance to be defined as 3/5 symptoms which include gastric residual volume \> 500 ml /day,absence of bowel sounds,vomitting/regurgitation,diarrhoea and bowel distension
次要结局
- Survival(7 days)
- Number of patients with Initiation of entral nutrition more than 50%. of recommended nutrition (Kcal/kg body weight/day).(72 hours)
- Number of patients without Ventilatory support in all the 3 groups.(7 days)
- Number of patients with resolution of atleast 2 out of 5 symptoms in all the 3 groups.(72 hours)
- Number of patients with resolution of sepsis, shock, organ failure in all the 3 groups.(7 days)
- Number of patients without inotropic supports in all the 3 groups.(7 days)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
4 期
Leptin and Ghrelin in ICUCritically IllNCT02282501özgür yağan40
已完成
不适用
Intensive Enteral Nutrition and Acute Alcoholic HepatitisSevere Alcoholic HepatitisNCT01801332Erasme University Hospital136
已完成
2 期
Probiotics in Enteral Feeding in Critically Ill PatientsCritical IllnessDietary ModificationProbioticsGut FailureTreatment OutcomesNCT01792401University of Malaya49
已完成
不适用
CONTINUation of Enteral Nutrition Prior to Extubation Compared to Standard CareCritical IllnessNCT06382727Emma Ridley60
终止
不适用
Early Cycle Ergometry for Critically-Ill Liver Failure Patients in a Transplant Intensive Care UnitLiver CirrhosesICU Acquired WeaknessLiver FailureNCT04160039Medical College of Wisconsin97